Glyco-engineering Using Pneumococcal Exoglycosidases: A Pilot Study on Deglycosylation of Human Alpha-1-Acid Glycoprotein
DOI:
https://doi.org/10.32628/IJSRST2512138Keywords:
Glyco-engineering, sialic acid, Streptococcus pneumoniae, glycosidases, NanA, BgaA, Lectin blotting, human alpha-1-acid glycoprotein (AGP1)Abstract
Glyco-engineering is an emerging field that focuses on modifying glycan structures to enhance or alter biological functions. Enzymatic glycan remodeling has numerous applications in biopharmaceuticals, vaccine development, and glycan-based diagnostics. Pneumococcal exoglycosidases, such as neuraminidase NanA and β-galactosidase BgaA, selectively hydrolyze terminal sugars from glycoconjugates, making them potential tools for glyco-engineering. However, their ability to modify human glycoproteins in vitro remains largely unexplored. In this study, we assessed the glyco-engineering potential of pneumococcal exoglycosidases by examining their role in deglycosylating human alpha-1-acid glycoprotein (AGP), a plasma glycoprotein involved in inflammation. Our results demonstrate that NanA removes terminal sialic acid residues from AGP, enabling subsequent galactose removal by BgaA, as confirmed by SDS-PAGE and lectin blot analysis. These findings provide experimental evidence supporting the utility of pneumococcal glycosidases for enzymatic glyco-engineering.
Downloads
References
Varki A. Biological roles of glycans. Glycobiology. 2017 Jan;27(1):3-49. doi: 10.1093/glycob/cww086. Epub 2016 Aug 24. PMID: 27558841. DOI: https://doi.org/10.1093/glycob/cww086
Hobbs JK, Pluvinage B, Boraston AB. Glycan-metabolizing enzymes in microbe-host interactions: the Streptococcus pneumoniae paradigm. FEBS Lett. 2018 Dec;592(23):3865-3897. doi: 10.1002/1873-3468.13045. Epub 2018 Apr 19. PMID: 29608212. DOI: https://doi.org/10.1002/1873-3468.13045
Mathew BJ, Gupta P, Naaz T, Rai R, Gupta S, Gupta S, Chaurasiya SK, Purwar S, Biswas D, Vyas AK, Singh AK. Role of Streptococcus pneumoniae extracellular glycosidases in immune evasion. Front Cell Infect Microbiol. 2023 Feb 3;13:1109449. doi: 10.3389/fcimb.2023.1109449. PMID: 36816580. DOI: https://doi.org/10.3389/fcimb.2023.1109449
King SJ. Pneumococcal modification of host sugars: a major contributor to colonization of the human airway? Mol Oral Microbiol. 2010 Feb;25(1):15-24. doi: 10.1111/j.2041-1014.2009.00564.x. PMID: 20331791. DOI: https://doi.org/10.1111/j.2041-1014.2009.00564.x
Hobbs JK, Pluvinage B, Robb M, Smith SP, Boraston AB. Two complementary α-fucosidases from Streptococcus pneumoniae promote complete degradation of host-derived carbohydrate antigens. J Biol Chem. 2019 Aug 23;294(34):12670-12682. doi: 10.1074/jbc.RA119.009368. Epub 2019 Jul 2. PMID: 31266803. DOI: https://doi.org/10.1074/jbc.RA119.009368
Beals JM, Shanafelt AB. Enhancing exposure of protein therapeutics. Drug Discov Today Technol. 2006 Spring;3(1):87-94. doi: 10.1016/j.ddtec.2006.03.001. PMID: 24980106. DOI: https://doi.org/10.1016/j.ddtec.2006.03.001
Zhang L, Luo S, Zhang B. Glycan analysis of therapeutic glycoproteins. MAbs. 2016;8(2):205-15. doi: 10.1080/19420862.2015.1117719. Epub 2015 Nov 24. PMID: 26599345. DOI: https://doi.org/10.1080/19420862.2015.1117719
Singh AK, Pluvinage B, Higgins MA, Dalia AB, Woodiga SA, Flynn M, Lloyd AR, Weiser JN, Stubbs KA, Boraston AB, King SJ. Unravelling the multiple functions of the architecturally intricate Streptococcus pneumoniae β-galactosidase, BgaA. PLoS Pathog. 2014 Sep 11;10(9):e1004364. doi: 10.1371/journal.ppat.1004364. PMID: 25210925. DOI: https://doi.org/10.1371/journal.ppat.1004364
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Scientific Research in Science and Technology
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
